ATE74517T1 - Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha. - Google Patents

Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.

Info

Publication number: ATE74517T1
Authority: AT; Austria
Prior art keywords: interferon; alpha; treatment; gamma; leukemias
Prior art date: 1987-01-20

Application number

AT88300407T

Other languages

English (en)

Inventor

Paul Philip Trotta

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-01-20

Filing date

1988-01-19

Publication date

1992-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21712239&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE74517(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-01-19 Application filed by Schering Corp filed Critical Schering Corp

1992-04-15 Application granted granted Critical

1992-04-15 Publication of ATE74517T1 publication Critical patent/ATE74517T1/de

Links

102000006992 Interferon-alpha Human genes 0.000 title abstract 2
108010047761 Interferon-alpha Proteins 0.000 title abstract 2
208000032839 leukemia Diseases 0.000 title abstract 2
102000008070 Interferon-gamma Human genes 0.000 title 1
108010074328 Interferon-gamma Proteins 0.000 title 1
229960003130 interferon gamma Drugs 0.000 title 1
102000014150 Interferons Human genes 0.000 abstract 2
108010050904 Interferons Proteins 0.000 abstract 2
210000001744 T-lymphocyte Anatomy 0.000 abstract 1
210000003719 b-lymphocyte Anatomy 0.000 abstract 1
229940079322 interferon Drugs 0.000 abstract 1
229940047124 interferons Drugs 0.000 abstract 1
230000002062 proliferating effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT88300407T 1987-01-20 1988-01-19 Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha. ATE74517T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US473187A	1987-01-20	1987-01-20
EP88300407A EP0276120B1 (de)	1987-01-20	1988-01-19	Behandlung von einigen Leukämien mit einer Zusammensetzung von Interferon-gamma und Interferon-alpha

Publications (1)

Publication Number	Publication Date
ATE74517T1 true ATE74517T1 (de)	1992-04-15

Family

ID=21712239

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88300407T ATE74517T1 (de)	1987-01-20	1988-01-19	Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.

Country Status (7)

Country	Link
EP (1)	EP0276120B1 (de)
JP (1)	JPS63198636A (de)
AT (1)	ATE74517T1 (de)
CA (1)	CA1321348C (de)
DE (1)	DE3869789D1 (de)
ES (1)	ES2039276T3 (de)
GR (1)	GR3004928T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2704546B2 (ja) *	1989-04-04	1998-01-26	光利太良	Ａｔｌｌ治療用吸入剤
TW201245229A (en)	2003-10-14	2012-11-16	Hoffmann La Roche	Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication
JP5249028B2 (ja)	2005-07-25	2013-07-31	インターミューン・インコーポレーテッド	Ｃ型肝炎ウイルス複製の新規大環状阻害剤
GEP20104956B (en)	2005-10-11	2010-04-12	Array Biopharma Inc	Compounds for inhibiting hepatitis c viral replication and use thereof
CU23432B6 (es)	2005-11-02	2009-10-16	Ct Ingenieria Genetica Biotech	Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5562024A (en) *	1978-10-31	1980-05-10	Hayashibara Takeshi	Preventive and remedy for interferon-sensitive disease
ZA83768B (en) *	1982-03-01	1983-10-26	Hoffmann La Roche	Homogeneous human immune interferon and process therefor
ATE52693T1 (de) *	1982-10-25	1990-06-15	Genentech Inc	Synergistische humaninterferonaktivitaet.
US4806347A (en) *	1985-12-11	1989-02-21	Schering Corporation	Interferon combinations
JPS61263929A (ja) *	1986-04-30	1986-11-21	Hayashibara Takeshi	抗タイプ２インターフェロン感受性疾患剤
US4851219A (en) *	1986-11-18	1989-07-25	Genentech, Inc.	Method for the treatment of chronic myelogenous leukemia

1988
- 1988-01-19 ES ES198888300407T patent/ES2039276T3/es not_active Expired - Lifetime
- 1988-01-19 AT AT88300407T patent/ATE74517T1/de not_active IP Right Cessation
- 1988-01-19 EP EP88300407A patent/EP0276120B1/de not_active Expired - Lifetime
- 1988-01-19 DE DE8888300407T patent/DE3869789D1/de not_active Expired - Lifetime
- 1988-01-20 CA CA000556924A patent/CA1321348C/en not_active Expired - Fee Related
- 1988-01-20 JP JP63010557A patent/JPS63198636A/ja active Pending
1992
- 1992-06-17 GR GR920401288T patent/GR3004928T3/el unknown

Also Published As

Publication number	Publication date
EP0276120A3 (en)	1989-10-04
DE3869789D1 (de)	1992-05-14
GR3004928T3 (de)	1993-04-28
JPS63198636A (ja)	1988-08-17
ES2039276T3 (es)	1993-09-16
CA1321348C (en)	1993-08-17
EP0276120A2 (de)	1988-07-27
EP0276120B1 (de)	1992-04-08

Similar Documents

Publication	Publication Date	Title
DK163279C (da)	1992-07-06	Multimineralkosttilskudstablet med kontrolleret afgivelse
DE3579453D1 (de)	1990-10-04	Monolithische integration von lichtemittierenden elementen und steuerelektronik.
NO875355D0 (no)	1987-12-21	Rensing av rekombinant beta-interferon innbefattende rp-hplc.
DE3381553D1 (de)	1990-06-21	Synergistische humaninterferonaktivitaet.
KR890701135A (ko)	1989-12-19	감마 인터페론 제제
DK201590D0 (da)	1990-08-22	Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse
DE3773295D1 (de)	1991-10-31	Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DE3869789D1 (de)	1992-05-14	Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
DK50987A (da)	1987-08-01	Polypeptid med plasminogenaktivatorvirkning
IL67896A (en)	1987-03-31	Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
ATE189262T1 (de)	2000-02-15	Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen
DE3767175D1 (de)	1991-02-14	Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
EP0248583A3 (en)	1989-10-18	Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
DE3777224D1 (de)	1992-04-16	Verwendung von interferon-beta und interleukin-2 in der kombinationstherapie und zusammensetzungen dazu.
NZ221406A (en)	1990-10-26	Antitumour composition containing an interleukin-2 active substance and an interferon-alpha
DK103891A (da)	1991-05-31	Intralaesional behandling af pladeepitelcarcinoma med rekombinant human alfainterferon
ATE112686T1 (de)	1994-10-15	Verwendungsmethoden von humanem gammainterferon 4-134.
NO891715L (no)	1989-10-26	Ekspresjon av interferon-gamma i metylotrofe gjaersorter.
DK527287D0 (da)	1987-10-08	Polypeptid med interleukin-2-aktiviteter
ATA292286A (de)	1990-03-15	Schultisch mit neigbarer tischplatte
ATE73346T1 (de)	1992-03-15	Verwendung von interferon-beta und interleukin-2 in der kombinationstherapie und zusammensetzungen dazu.
PT81147B (de)	1987-03-30	Bekaempfung von durchfaellen mit alpha-interferonen
ES1000854Y (es)	1988-10-01	Mesa de billar perfeccionada
BR6600321U (pt)	1987-09-29	Estruturas metalicas de cadeira e mesa
DK0381584T3 (da)	1994-02-14	Anvendelse af visse gamma-interferoner til behandling af ovariecancer

Legal Events

Date	Code	Title
1992-11-15	UEP	Publication of translation of european patent specification
1996-10-15	REN	Ceased due to non-payment of the annual fee
1996-12-15	RZN	Patent revoked